Nagao M, Nakayasu M, Aonuma S, Wakabayashi K, Hirose M, Sugimura T
Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.
Mutat Res. 1991 Aug;253(1):97-102. doi: 10.1016/0165-1161(91)90350-h.
The mutagenicity of the base analogue, 2-amino-N6-hydroxyadenine (AHA), was tested in Salmonella typhimurium TA100 and TA98 and in Chinese hamster lung (CHL) cells. AHA showed very potent mutagenicity in TA100 without S9 mix, inducing 25,000 revertants/micrograms. The mutagenicity increased about 2-fold upon addition of S9 mix containing 10 microliters S9. AHA was found to be one of the strongest mutagens for TA100. Addition of S9 mix containing 100 microliters S9 induced no significant increase of revertants with AHA at amounts up to 50 ng per plate. AHA was also mutagenic for the frameshift mutant, TA98, without S9 mix, the mutagenicity for TA98 being about 1/1000 of that for TA100. When the mutagenicity of AHA was tested in CHL cells, with diphtheria toxin resistance (DTr) as a selective marker in the absence of S9 mix with a 3-h treatment of cells, DTr mutants increased dose-dependently at concentrations of 2.5-15 micrograms/ml. When cells were incubated with AHA for 24 h, a 200-fold increase in the number of DTr mutants was observed; the mutagenicity was 500-fold higher than that of ethyl methanesulfonate. This marked increase of mutagenicity by prolonged incubation may indicate that AHA induces mutations mainly after incorporation into DNA. The addition of a small amount of S9 increased the mutagenicity obtained with a 3-h treatment 2-fold, but a larger amount of S9 decreased the mutagenicity as was found with S. typhimurium TA100.
在鼠伤寒沙门氏菌TA100和TA98以及中国仓鼠肺(CHL)细胞中测试了碱基类似物2-氨基-N6-羟基腺嘌呤(AHA)的致突变性。AHA在无S9混合物的TA100中表现出很强的致突变性,诱导25,000个回复突变体/微克。加入含有10微升S9的S9混合物后,致突变性增加了约2倍。发现AHA是TA100最强的诱变剂之一。加入含有100微升S9的S9混合物后,每平板AHA含量高达50纳克时,回复突变体数量没有显著增加。AHA对移码突变体TA98也有致突变性,无S9混合物时,对TA98的致突变性约为对TA100的1/1000。当在CHL细胞中测试AHA的致突变性时,以抗白喉毒素(DTr)作为选择标记,在无S9混合物且细胞处理3小时的情况下,DTr突变体在2.5 - 15微克/毫升的浓度下呈剂量依赖性增加。当细胞与AHA孵育24小时时,观察到DTr突变体数量增加了200倍;致突变性比甲磺酸乙酯高500倍。长时间孵育导致的这种致突变性显著增加可能表明AHA主要在掺入DNA后诱导突变。加入少量S9可使3小时处理获得的致突变性增加2倍,但大量S9会降低致突变性,这与鼠伤寒沙门氏菌TA100的情况相同。